Evidence map›Paper›PMID 25762741›Full record

ArticleJournal of virology2015

Degradation of SAMHD1 by Vpx Is Independent of Uncoating.

Paula Jáuregui, Eric C Logue, Megan L Schultz, Stephanie Fung, Nathaniel R Landau

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The role of SAMHD1 expression and its relation to HIV-2 (Vpx) gene production.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Paula JáureguiDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Eric C LogueDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Megan L SchultzDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Stephanie FungDepartment of Microbiology, New York University School of Medicine, New York, New York, USA.
Nathaniel R LandauDepartment of Microbiology, New York University School of Medicine, New York, New York, USA Nathaniel.Landau@med.nyu.edu.
New York University · US

Funding

APOBEC3G/CEM15 Inhibition of Lentivirus ReplicationR01AI058864 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI LANDAU, NATHANIEL R. · 2004 to 2015
$4.5M
Vpr RevisitedR01AI067059 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LANDAU, NATHANIEL R. · 2008 to 2017
$3.4M
NIAID NIH HHS AI058864NIAID NIH HHS AI067059NIAID NIH HHS R01 AI058864NIAID NIH HHS R01 AI067059
6 · The paper itself

Abstract

unlabelledSterile alpha motif domain and HD domain-containing protein 1 (SAMHD1) restricts human immunodeficiency virus type 1 (HIV-1) replication in myeloid and resting T cells. Lentiviruses such as HIV-2 and some simian immunodeficiency viruses (SIVs) counteract the restriction by encoding Vpx or Vpr, accessory proteins that are packaged in virions and which, upon entry of the virus into the cytoplasm, induce the proteasomal degradation of SAMHD1. As a tool to study these mechanisms, we generated HeLa cell lines that express a fusion protein termed NLS.GFP.SAM595 in which the Vpx binding domain of SAMHD1 is fused to the carboxy terminus of green fluorescent protein (GFP) and a nuclear localization signal is fused to the amino terminus of GFP. Upon incubation of Vpx-containing virions with the cells, the NLS.GFP.SAM595 fusion protein was degraded over several hours and the levels remained low over 5 days as the result of continued targeting of the CRL4 E3 ubiquitin ligase. Degradation of the fusion protein required that it contain a nuclear localization sequence. Fusion to the cytoplasmic protein muNS rendered the protein resistant to Vpx-mediated degradation, confirming that SAMHD1 is targeted in the nucleus. Virions treated with protease inhibitors failed to release Vpx, indicating that Gag processing was required for Vpx release from the virion. Mutations in the capsid protein that altered the kinetics of virus uncoating and the Gag binding drug PF74 had no effect on the Vpx-mediated degradation. These results suggest that Vpx is released from virions without a need for uncoating of the capsid, allowing Vpx to transit to the nucleus rapidly upon entry into the cytoplasm. IMPORTANCE: SAMHD1 restricts lentiviral replication in myeloid cells and resting T cells. Its importance is highlighted by the fact that viruses such as HIV-2 encode an accessory protein that is packaged in the virion and is dedicated to inducing SAMHD1 degradation. Vpx needs to act rapidly upon infection to allow reverse transcription to proceed. The limited number of Vpx molecules in a virion also needs to clear the cell of SAMHD1 over a prolonged period of time. Using an engineered HeLa cell line that expresses a green fluorescent protein (GFP)-SAMHD1 fusion protein, we showed that the Vpx-dependent degradation occurs without a need for viral capsid uncoating. In addition, the fusion protein was degraded only when it was localized to the nucleus, confirming that SAMHD1 is targeted in the nucleus and thus explaining why Vpx also localizes to the nucleus.

Indexed as

Capsid Proteinsgag Gene Products, Human Immunodeficiency VirusHEK293 CellsHeLa CellsHIV-1HIV-2Host-Pathogen InteractionsHumansMonomeric GTP-Binding ProteinsMutationProtein Processing, Post-TranslationalProteolysisRecombinant Fusion ProteinsSAM Domain and HD Domain-Containing Protein 1Simian Immunodeficiency VirusViral Regulatory and Accessory ProteinsCapsid Proteinsgag Gene Products, Human Immunodeficiency VirusMonomeric GTP-Binding ProteinsRecombinant Fusion ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanViral Regulatory and Accessory ProteinsVPX protein, Human immunodeficiency virus 2

Identifiers

PMID25762741
PMCPMC4442547
OpenAlexW2031359994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.